KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Gains from Investment Securities (2016 - 2025)

Elevance Health (ELV) has disclosed Gains from Investment Securities for 17 consecutive years, with -$20.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities changed N/A to -$20.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $32.0 million, a N/A change, with the full-year FY2025 number at $32.0 million, changed N/A from a year prior.
  • Gains from Investment Securities was -$20.0 million for Q4 2025 at Elevance Health, down from $12.0 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $71.0 million in Q2 2023 to a low of -$20.0 million in Q4 2025.
  • A 5-year average of $23.1 million and a median of $25.0 million in 2025 define the central range for Gains from Investment Securities.
  • Peak YoY movement for Gains from Investment Securities: crashed 85.39% in 2021, then surged 136.67% in 2023.
  • Elevance Health's Gains from Investment Securities stood at $13.0 million in 2021, then plummeted by 84.62% to $2.0 million in 2022, then surged by 3450.0% to $71.0 million in 2023, then crashed by 42.25% to $41.0 million in 2024, then crashed by 148.78% to -$20.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELV's Gains from Investment Securities are -$20.0 million (Q4 2025), $12.0 million (Q3 2025), and $15.0 million (Q2 2025).